These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30616151)

  • 1. Relationship between N,N-dimethylformamide exposure, PNPLA3, GCKR, COL13A1 and TM6SF2 genes, and liver injury.
    Zhang X; Jiang H; Shen J; Zhang Y; Gu Y; Xiao J; Lian Y
    Ecotoxicol Environ Saf; 2019 Apr; 171():347-351. PubMed ID: 30616151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose N,N-Dimethylformamide Exposure and Liver Injuries in a Cohort of Chinese Leather Industry Workers.
    Qi C; Gu Y; Sun Q; Gu H; Xu B; Gu Q; Xiao J; Lian Y
    J Occup Environ Med; 2017 May; 59(5):434-439. PubMed ID: 28368964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population.
    Larrieta-Carrasco E; Flores YN; Macías-Kauffer LR; Ramírez-Palacios P; Quiterio M; Ramírez-Salazar EG; León-Mimila P; Rivera-Paredez B; Cabrera-Álvarez G; Canizales-Quinteros S; Zhang ZF; López-Pérez TV; Salmerón J; Velázquez-Cruz R
    Exp Mol Pathol; 2018 Feb; 104(1):50-58. PubMed ID: 29307798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.
    Kitamoto A; Kitamoto T; Nakamura T; Ogawa Y; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Nakao K; Sekine A; Chayama K; Nakajima A; Hotta K
    Endocr J; 2014; 61(7):683-9. PubMed ID: 24785259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.
    Lin YC; Chang PF; Chang MH; Ni YH
    Liver Int; 2018 Jul; 38(7):1300-1307. PubMed ID: 29314568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.
    Hernaez R; McLean J; Lazo M; Brancati FL; Hirschhorn JN; Borecki IB; Harris TB; ; Nguyen T; Kamel IR; Bonekamp S; Eberhardt MS; Clark JM; Kao WH; Speliotes EK
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1183-1190.e2. PubMed ID: 23416328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparative Benchmark Dose Study for N, N-Dimethylformamide Induced Liver Injury in a Chinese Occupational Cohort.
    Wu Z; Liu Q; Wang C; Xu B; Guan M; Ye M; Jiang H; Zheng M; Zhang M; Zhao W; Jiang X; Leng S; Cheng J
    Toxicol Sci; 2017 Jul; 158(1):140-150. PubMed ID: 28505332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GWAS-Identified Common Variants With Nonalcoholic Fatty Liver Disease in Chinese Children.
    Shang XR; Song JY; Liu FH; Ma J; Wang HJ
    J Pediatr Gastroenterol Nutr; 2015 May; 60(5):669-74. PubMed ID: 25522307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between CYP2E1 and GOT2 gene polymorphisms and susceptibility and low-dose N,N-dimethylformamide occupational exposure-induced liver injury.
    Jiang H; Zhang X; Shen J; Zhang Y; Gu Y; Tian T; Chu M; Zhuang X; Lian Y
    Int Arch Occup Environ Health; 2019 Oct; 92(7):967-975. PubMed ID: 30993423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects.
    Sliz E; Sebert S; Würtz P; Kangas AJ; Soininen P; Lehtimäki T; Kähönen M; Viikari J; Männikkö M; Ala-Korpela M; Raitakari OT; Kettunen J
    Hum Mol Genet; 2018 Jun; 27(12):2214-2223. PubMed ID: 29648650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults.
    Flores YN; Velázquez-Cruz R; Ramírez P; Bañuelos M; Zhang ZF; Yee HF; Chang SC; Canizales-Quinteros S; Quiterio M; Cabrera-Alvarez G; Patiño N; Salmerón J
    Mol Biol Rep; 2016 Dec; 43(12):1359-1369. PubMed ID: 27752939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum activities of liver enzymes in workers exposed to sub-TLV levels of dimethylformamide.
    He J; Liu J; Kong Y; Yang W; Zhang Z
    Int J Occup Med Environ Health; 2015; 28(2):395-8. PubMed ID: 26182934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non-alcoholic fatty liver disease.
    Grove JI; Thiagarajan P; Astbury S; Harris R; Delahooke T; Guha IN; Aithal GP
    Liver Int; 2018 Oct; 38(10):1832-1838. PubMed ID: 29493856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The deleterious effects of N,N-dimethylformamide on liver: A mini-review.
    Li MJ; Zeng T
    Chem Biol Interact; 2019 Jan; 298():129-136. PubMed ID: 30576622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China.
    Liao S; An K; Liu Z; He H; An Z; Su Q; Li S
    J Clin Lab Anal; 2022 Sep; 36(9):e24626. PubMed ID: 35881683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships among N,N-dimethylformamide exposure, CYP2E1 and TM6SF2 genes, and non-alcoholic fatty liver disease.
    Zhou Z; Sang L; Wang J; Song L; Zhu L; Wang Y; Xiao J; Lian Y
    Ecotoxicol Environ Saf; 2021 Nov; 228():112986. PubMed ID: 34794021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal liver function associated with occupational exposure to dimethylformamide and glutathione S-transferase polymorphisms.
    Luo JC; Cheng TJ; Kuo HW; Chang MJ
    Biomarkers; 2005; 10(6):464-74. PubMed ID: 16308270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma].
    Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease.
    Petta S; Miele L; Bugianesi E; Cammà C; Rosso C; Boccia S; Cabibi D; Di Marco V; Grimaudo S; Grieco A; Pipitone RM; Marchesini G; Craxì A
    PLoS One; 2014; 9(2):e87523. PubMed ID: 24498332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship among GNB3 rs5443, PNPLA3 rs738409, GCKR rs780094 gene polymorphisms, type of maternal gestational weight gain and neonatal outcomes (STROBE-compliant article).
    Mărginean C; Mărginean CO; Bănescu C; Meliţ LE; Tripon F; Iancu M
    Medicine (Baltimore); 2019 Jul; 98(28):e16414. PubMed ID: 31305457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.